{"disease":{"id":"neuroendocrine-tumour","name":"neuroendocrine tumour"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01578239","title":"A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Advanced Accelerator Applications","has_results":true},{"nct_id":"NCT07185672","title":"PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":162,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false},{"nct_id":"NCT02923934","title":"A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Olivia Newton-John Cancer Research Institute","has_results":false},{"nct_id":"NCT06121271","title":"Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT03592940","title":"The Management of Neuroendocrine Tumours: A Nutritional Viewpoint.","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT06043193","title":"Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT02651987","title":"Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Ipsen","has_results":true},{"nct_id":"NCT00323076","title":"[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":92,"lead_sponsor_name":"AHS Cancer Control Alberta","has_results":false},{"nct_id":"NCT04649580","title":"United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT04579679","title":"Open-Label Surufatinib in European Patients With NET","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":78,"lead_sponsor_name":"Hutchmed","has_results":true},{"nct_id":"NCT03033186","title":"Everolimus TDM to Predict Long Term Toxicity","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT03328065","title":"Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours","phase":"","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT07279532","title":"Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07077564","title":"The Efficacy of TROP2-ADC in Advanced Extrapulmonary High-Grade Neuroendocrine Neoplasms Failure of Standard Therapy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04525638","title":"A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Fundación de investigación HM","has_results":false},{"nct_id":"NCT04837885","title":"Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":23,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT07404176","title":"Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false},{"nct_id":"NCT02713763","title":"Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Grupo Espanol de Tumores Neuroendocrinos","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}